Here, we also discussed the available evidence showing the ability of BETi to disrupt long-range chromatin interaction on mutated TERT promoter such as to inhibit c-Myc and AP-1 transcriptional activities independently from tumor genetic background (Figure 1) [34,41,42,54]. This evidence concerns the gene TERT and neoplasm.